Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the Literature.


Jacobs SE, Saez-Lacy D, Wynkoop W, Walsh TJ.
Open Forum Infect Dis. 2017 May 5;4(2):ofx040.


Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked improvement and minimal adverse effects. We further review the literature on antifungal management of ABPA.


allergic bronchopulmonary aspergillosis; antifungal therapy; isavuconazole.